Ryan, Julie L, Carroll, Jennifer K, Ryan, Elizabeth P et al. · The oncologist · 2007 · DOI
Cancer-related fatigue is extreme tiredness that happens during and after cancer treatment and significantly impacts quality of life, but doctors don't fully understand why it occurs. This review examines several possible causes, including problems with brain chemicals, muscle metabolism, hormonal balance, sleep-wake cycles, and inflammation in the body. Understanding these mechanisms could help develop better treatments for this distressing symptom.
This review is significant for ME/CFS research because it explicitly identifies chronic fatigue syndrome as a key comparator condition for understanding fatigue pathophysiology and highlights multiple overlapping biological mechanisms—including cytokine dysregulation, circadian disruption, and autonomic dysfunction—that are also implicated in ME/CFS. Clarifying these shared mechanisms may provide a translational bridge between cancer research and ME/CFS, potentially informing treatment development for both conditions.
This review does not establish causal mechanisms in cancer-related fatigue, nor does it provide empirical data quantifying the relative contribution of each proposed mechanism to CRF symptoms. The mechanistic hypotheses are largely extrapolated from other conditions rather than tested directly in cancer populations, so applicability to ME/CFS requires independent validation in ME/CFS cohorts.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.